MeSH tree: C12.050.351.937
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced ...
Nov 10, 2025
0
11
Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Nov 10, 2025
0
11
The American College of Medical Genetics and Genomics (ACMG) has published a new clinical practice resource, "Management of Individuals with Heterozygous Germline Pathogenic Variants in RAD51C, RAD51D, and BRIP1: A clinical ...
Nov 10, 2025
0
10
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.
Nov 3, 2025
0
25
If you're reading this, there's a good chance that you, like me, are a millennial. If so, you've probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later ...
Oct 29, 2025
0
14
One in five women with breast or cervical cancer in low- and middle-income countries (LMICs) are diagnosed at an early stage, compared with more than one in three in high-income countries (HICs), new research suggests. For ...
Oct 22, 2025
0
15
FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patients with advanced urothelial carcinoma, according ...
Oct 22, 2025
0
9
KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of pembrolizumab-based immunotherapy and targeted treatments for advanced clear cell renal cell carcinoma ...
Oct 21, 2025
0
25
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
Oct 20, 2025
0
17
Results from a trial led by researchers from The University of Texas MD Anderson Cancer Center showed that a targeted therapy combination improved outcomes for patients with metastatic clear-cell renal carcinoma (ccRCC)—a ...
Oct 20, 2025
0
19
